Status
Conditions
Treatments
About
To investigate the motor development, motor function and electrodiagnostics presentation in IOPD under ERT.
Full description
Background
Pompe disease is an autosomal recessive disease, enzyme replacement therapy (ERT) and new born screen (NBS) had been initiated in Taiwan since 2008. However, residual muscle weakness were noted. Decrease in amplitude of nerve compound muscle action potential (CMAP) and increase spontaneous activity were reported before the imitation of ERT. However, the motor development, motor function and electrodiagnostic presentation which were important in further direction of treatment and rehabilitation program arrangement in infantile Pompe disease (IOPD) under ERT is lacking.
Aim
To investigate the motor development, motor function and electrodiagnostic presentation in IOPD under ERT.
Method
This is an observational, prospective, longitudinal, follow-up study. Motor development was assessed by Alberta Infant Motor Scale (AIMS) and Peabody Developmental Motor Scales, Second Edition (PDMS II); motor function was assessed by Pediatric Evaluation of Disability Inventory (PEDI) and Gross Motor Function Measure (GMFM). Electrodiagnosis studies include nerve conduction study (NCS) and electromyography (EMG).
Expect Effects
Obtain the characteristics of motor development, motor function and electrodiagnosis presentation of IOPD under ERT, and the relation between motor development, motor function and electrodiagnosis presentation.
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
15 participants in 1 patient group
Loading...
Central trial contact
chihjou lai
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal